Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012930 ◽

2018 ◽

Author(s):

Usman Maqsood ◽

David JW Evans ◽

Terence N Ho ◽

Karen Palmer ◽

Fiona JR Eccles ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Once daily Long-acting beta2 -agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012355 ◽

2016 ◽

Author(s):

Agnieszka Sliwka ◽

Milosz Jankowski ◽

Iwona Gross-Sondej ◽

Roman Nowobilski ◽

Malgorzata M Bala

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Once daily long‐acting beta 2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

International Journal of Nursing Practice ◽

10.1111/ijn.12982 ◽

2021 ◽

Author(s):

Abdullahi S. Ibrahim

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Beta 2 ◽

Download Full-text

Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012355.pub2 ◽

2018 ◽

Author(s):

Agnieszka Sliwka ◽

Milosz Jankowski ◽

Iwona Gross-Sondej ◽

Monika Storman ◽

Roman Nowobilski ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Beta Agonists ◽

Download Full-text

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012930.pub2 ◽

2019 ◽

Author(s):

Usman Maqsood ◽

Terence N Ho ◽

Karen Palmer ◽

Fiona JR Eccles ◽

Mohammed Munavvar ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease

Future Medicinal Chemistry ◽

10.4155/fmc.11.127 ◽

2011 ◽

Vol 3 (13) ◽

pp. 1623-1634 ◽

Author(s):

Jakob Busch-Petersen ◽

Dramane I Lainé

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2019.05.010 ◽

2019 ◽

Vol 153 ◽

pp. 38-43 ◽

Author(s):

James F. Donohue ◽

Edward Kerwin ◽

Sanjay Sethi ◽

Brett Haumann ◽

Srikanth Pendyala ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Phase 3 ◽

Obstructive Pulmonary Disease ◽

Muscarinic Antagonist ◽

Download Full-text

COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Respirology ◽

10.1111/resp.13420_435 ◽

2018 ◽

Vol 23 ◽

pp. 247-247

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Beta Agonists ◽

Download Full-text

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s35990 ◽

2012 ◽

pp. 673 ◽

Author(s):

Charlotte Ulrik

Keyword(s):

Systematic Review ◽

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Clinical Benefit ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Muscarinic Antagonist ◽

Glycopyrronium Bromide ◽

Download Full-text

Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/ajrccm.161.4.9903044 ◽

2000 ◽

Vol 161 (4) ◽

pp. 1136-1142 ◽

Author(s):

MICHAEL R. LITTNER ◽

JONATHAN S. ILOWITE ◽

DONALD P. TASHKIN ◽

MITCHELL FRIEDMAN ◽

CHARLES W. SERBY ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd011282 ◽

2014 ◽

Author(s):

Michael Sarai ◽

Don Sin ◽

J. Mark FitzGerald ◽

Shawn Aaron

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text